Petrov2018 - C-547 a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase Lab
About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
C-547, a candidate drug, is a potent slow-binding inhibitor of acetyl-cholinesterase, and the focus of this PK/PD model, which investigates the metabolism and clinical effect of C-547 when it is no lo. It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_c547_binding_state_y1",
"label": "Initial C547 Binding State Y1",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y1"
},
{
"name": "initial_c547_binding_state_y2",
"label": "Initial C547 Binding State Y2",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y2"
},
{
"name": "initial_c547_binding_state_y3",
"label": "Initial C547 Binding State Y3",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y3"
},
{
"name": "initial_c547_binding_state_y4",
"label": "Initial C547 Binding State Y4",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y4"
},
{
"name": "initial_c547_binding_state_y5",
"label": "Initial C547 Binding State Y5",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.initial_c547_binding_state_y5"
}
],
"outputs": [
{
"name": "state",
"label": "Tracked source state",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.state"
},
{
"name": "summary",
"label": "Simulation summary",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.summary"
},
{
"name": "species_labels",
"label": "Observable labels",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.species_labels"
},
{
"name": "c547_binding_state_y1",
"label": "C547 Binding State Y1",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y1"
},
{
"name": "c547_binding_state_y2",
"label": "C547 Binding State Y2",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y2"
},
{
"name": "c547_binding_state_y3",
"label": "C547 Binding State Y3",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y3"
},
{
"name": "c547_binding_state_y4",
"label": "C547 Binding State Y4",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y4"
},
{
"name": "c547_binding_state_y5",
"label": "C547 Binding State Y5",
"maps_to": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.c547_binding_state_y5"
}
]
},
"tags": [
"pharmacology",
"receptor-binding",
"neuroscience",
"toxicology",
"sbml",
"tellurium",
"faithful",
"biomodels_ebi"
],
"title": "Petrov2018 - C-547 a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase Lab",
"models": [
{
"path": "models/core",
"alias": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model",
"parameters": {
"model_path": "data/MODEL1910240001.xml",
"integration_step": 0.2
}
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_state"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.state"
},
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_summary"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.summary"
},
{
"to": [
"visualisation.pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model_species_labels"
],
"from": "pharmacology_sbml_petrov2018_c_547_a_6_methyluracil_derivative_wit_model1910240001_model.species_labels"
}
],
"package": "petrov2018-c547-acetylcholinesterase-binding",
"runtime": {
"duration": 60,
"initial_inputs": {},
"communication_step": 2
},
"version": "1.0.0",
"description": "C-547, a candidate drug, is a potent slow-binding inhibitor of acetyl-cholinesterase, and the focus of this PK/PD model, which investigates the metabolism and clinical effect of C-547 when it is no lo. It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.",
"schema_version": "2.0"
}Runtime
Duration60
Comms Step2
Runs
Total0
Completed0
Failed0
Metadata
Packagepetrov2018-c547-acetylcholinesterase-binding
Created2026-05-16
Updated2026-06-13
pharmacologyreceptor-bindingneurosciencetoxicologysbmltelluriumfaithfulbiomodels_ebivisualisationother